Abnormal lipid metabolism and its restoration by dietary methionine (Met) and cystine (Cys) were studied in Donryu rats subcutaneously implanted with an ascites hepatoma cell line of AH109A. The hepatoma-bearing rats exhibited hyperlipidemia characterized by rises in serum triglyceride and cholesterol levels. Decreased lipoprotein lipase (LPL) activities in epididymal adipose tissue, cardiac muscle, and gastrocnemius as well as increased fatty acid mobilization from adipose tissue were considered to be responsible for the hepatoma-induced hypertriglyceridemia, while increased hepatic cholesterogenesis and decreased steroid excretion into feces were thought to be responsible for the hepatoma-induced hypercholesterolemia. Dietary-supplemented Met or Cys reduced the AH109A-induced hypertriglyceridemia with suppression of fatty acid synthesis in the host liver. Met restored the fall of LPL activities, while Cys did not. Dietary Met or Cys also reduced the hypercholesterolemia with restoration of decreased bile acid excretion into feces. These results suggest that dietary Met or Cys is hypolipidemic in the hepatoma-bearing rats with slight differences in their modes of action.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11745-998-0287-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of an immunosuppressed orthotopic hepatocellular carcinoma rat model for the evaluation of chemo- and radioembolization therapies.
Eur J Pharm Biopharm
March 2024
Faculty of Pharmaceutical Sciences, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, CANADA; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark. Electronic address:
Article Synopsis
- * The study developed a rat model using N1S1 hepatoma cells to better understand tumor growth and test new treatments, observing tumor formation within days and varying tumor take rates across rat types.
- * Results suggest that immunocompetent SD rats show inconsistent tumor regression, making them unsuitable for therapy research, while immunosuppressed RNU rats provide reliable tumor growth for future investigations.
Repeated trans-arterial treatments of LDL-DHA nanoparticles induce multiple pathways of tumor cell death in hepatocellular carcinoma bearing rats.
Front Oncol
November 2022
Advanced Imaging Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States.
Introduction: Repeated hepatic arterial delivery of therapeutic agents to the liver by percutaneously implanted port-catheter systems has been widely used to treat unresectable liver cancer. This approach is applied to assess the therapeutic efficacy of repeated low-density lipoprotein-docosahexaenoic acid (LDL-DHA) nanoparticle treatments in a rat model of hepatocellular carcinoma.
Methods: N1S1 hepatoma bearing rats underwent placement of a percutaneously implanted hepatic artery port-catheter system and were allocated to untreated, control LDL-triolein (LDL-TO) or LDL-DHA nanoparticle infusions groups.
Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice.
Cancers (Basel)
April 2022
Department of Neurosciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.
Cancer cachexia consists of dramatic body weight loss with rapid muscle depletion due to imbalanced protein homeostasis. We found that the mRNA levels of apelin decrease in muscles from cachectic hepatoma-bearing rats and three mouse models of cachexia. Furthermore, expression inversely correlates with in muscle biopsies from cancer patients.
View Article and Find Full Text PDFThe Activity Screening of Hmong Herbs and an Antitumor Effect Study.
Evid Based Complement Alternat Med
October 2020
Basic Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guian, China.
Aim: To screen active sites from roots, stems, and leaves of and study its antitumor effect.
Methods: Human liver cancer HuH-7 cells were used to screen the active sites of . by MTT assay, and the polar extracts were analyzed by high-performance liquid chromatography (HPLC).
Active pyruvate dehydrogenase and impaired gluconeogenesis in orthotopic hepatomas of rats.
Metabolism
December 2019
Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Internal Medicine, University of Texas Southwestern Medical Center, USA. Electronic address:
Article Synopsis
- The study investigates the role of pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC) in the metabolism of hepatomas by examining pyruvate's integration into the TCA cycle in rats with liver tumors.
- Findings revealed that in hepatomas, pyruvate enters the TCA cycle only through PDH due to reduced levels of the regulatory enzyme pyruvate dehydrogenase kinase (PDK) 2/4, while the contribution of PC is minimal.
- Notably, unlike many cancer studies, these hepatomas exhibited low levels of lactate production and distinct metabolic profiles, underlining significant differences from normal liver and previous research on cancer metabolism.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!